What lies ahead for Paytm stock after Vijay Shekhar Sharma firm turns profitable; should you buy, sell, hold-
时间:2024-09-29 04:22:55 阅读(143)
Paytm achieved profitability three quarters ahead of its guidance, causing the market sentiment regarding the payment aggregator and financial services firm to turn positive, and sending the share price soaring. The company reported a revenue of Rs 2,062 crore in Q3FY23, up 42% on-year, while the firm’s contribution profit was up 131% on-year at Rs 1,048 crore. The stock has seen a rise of 28% from Friday’s closing price, regaining the interest of traders and investors.Paytm Stock CallsBoFa Securities: Neutral
Target Price: Rs 730CMP: Rs 524.95Upside: 39%
Goldman Sachs: BuyTarget Price: Rs 1,150CMP: Rs 524.9Upside: 119.1%
Goldman Sachs raised its FY24/FY25 adjusted EBITDA estimates for Paytm by 30%/14% on the back of Q3FY23 results. The journey to profitability was one quarter ahead of their recently upgraded expectation. The brokerage also said they expect the profits to sustain and with strong traction in disbursals, operating leverage, and UPI reimbursement, they expect the EBITDA margin to expand. This, to Goldman Sachs, is a significant catalyst for the stock.
The current stock price, according to the company’s analysis, suggests Paytm’s current share price is already pricing in multiple headwinds, with the stock trading close to its bear-case implied value; we see risk-reward as skewed to the upside. Paytm’s valuation multiples are at a discount to global/India peers, said Goldman Sachs.
Macquarie Research: OutperformTarget Price: Rs 800CMP: Rs 588Upside: 36.1%
Macquarie Research double-upgraded the digital financial services firm from underperform to outperform as the quarter ending December’s results surprised the markets by a wide margin. “At the time of listing, profit and free cash flow were not even a part of management’s discussion. However, we see a very visible change in approach of management to deliver profit, evidenced, we believe, by the core EBITDA profitability that was reported recently,” said the research firm.
(The stock recommendations in this story are by the respective research analysts and brokerage firms. FinancialExpress.com does not bear any responsibility for their investment advice. Capital markets investments are subject to rules and regulations. Please consult your investment advisor before investing.)
猜你喜欢
- Markets to remain volatile in near-term; use opportunities to build positions in cos with growth potential
- FDA allows imports of syphilis drug alternate during shortage
- Crude set to see price shift despite decline on weak global sentiment
- Continuum Green Energy raises $350 million in debt from international investors
- Medi Assist sets Rs 397-418 price band for its Rs 1,172 crore IPO
- CoinDCX to fund investors in asset transfers
- F&O Outlook- FIIs forming short positions, may not bode well for markets; traders advised to lighten up longs
- Markets Wrap – Mon, 20 Mar ‘23- Nifty, Sensex tank, rupee falls; Asia, US markets, Gold, Crude updates
- Constrained to seek CVC enquiry into TD Power’s irregularities, non-disclosures, says Vijay Kirloskar